NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.

類似資料

• NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.
  著者:: Mukherjee, S, 等
  出版事項: (2015)
• NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
  著者:: Mukherjee, S, 等
  出版事項: (2017)
• NeoSCOPE RTTQA: pre-accrual and on-trial review of all patients in a UK oesophageal RT trial
  著者:: Evans, E, 等
  出版事項: (2018)
• Preliminary phase IISOCRATES study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (IRT) in patients (pts) with locally advanced rectal cancer (LARC).
  著者:: Glynne-Jones, R, 等
  出版事項: (2004)
• Socrates phase II study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (RT) in patients (pts) with locally advanced rectal cancer (LARC).
  著者:: Glynne-Jones, R, 等
  出版事項: (2005)